Alcon Acquires Neurotech and ENCELTO, the Only FDA-Approved Treatment for MacTel Type 2
Alcon Inc ALC
News
Alcon Acquires Neurotech and ENCELTO, the Only FDA-Approved Treatment for MacTel Type 2
FDA Approves Alcon’s BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes
Alcon Gets FDA Approval for Brytly Eye Drops
FDA Approves Alcon’s BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes
Alcon Launches UNITY M, a Premium Ophthalmic Microscope Delivering Precise Control
Alcon Prices EUR 500 Million Senior Notes Offering
Alcon Prices EUR 500 Million Senior Notes Offering
New Product Launches and Strong Commercial Execution Drive Alcon's Second-Quarter 2026 Growth
New Product Launches and Strong Commercial Execution Drive Alcon's Second-Quarter 2026 Growth
Lensar Share Slide on Terminated Merger Deal With Alcon
Lensar and Alcon Agree to Terminate Merger
Staar Surgical Shareholders Reject $1.6 Billion Acquisition by Alcon in Activist Win
Broadwood Partners Still Opposes Alcon's Higher Bid for Staar Surgical
Staar Surgical Shares Surge as Alcon Boosts its Buyout Price
Alcon Upgrades Offer Price for Staar Surgical
Alcon Shares in Switzerland Climb After Guidance Confirmation
Alcon, Staar Surgical Amend Merger Agreement to Allow Other Bids
United States